Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changgui Li

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
International Journal of Rheumatic Diseases|August 25, 2025
2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common ComorbiditiesChanggui Li, Mingshu Sun, Zhen Liu, et al.
Annals of the Rheumatic Diseases|April 19, 2026
Musculoskeletal ultrasound findings in people with asymptomatic hyperuricemia: baseline analysis from the Transitions in Gout Research (TIGER) study using the OMERACT gout ultrasound semiquantitative scoring systemSarah Stewart, Gregory D Gamble, William J Taylor, et al.
Science (New York, N.Y.)|May 8, 2020
Development of an inactivated vaccine candidate for SARS-CoV-2Qiang Gao, Linlin Bao, Haiyan Mao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2024
Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout CohortAichang Ji, Yang Sui, Xiaomei Xue, et al.
Science Bulletin|May 31, 2022
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2Junyu Chen, Pui Wang, Lunzhi Yuan, et al.
Nature Genetics|October 10, 2017
Genome-wide association analysis identifies 30 new susceptibility loci for schizophreniaZhiqiang Li, Jianhua Chen, Hao Yu, et al.
The Lancet. Respiratory Medicine|November 18, 2023
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
Nature Communications|July 11, 2023
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamstersLiang Zhang, Yao Jiang, Jinhang He, et al.
Nature Communications|May 14, 2015
Genome-wide association analysis identifies three new risk loci for gout arthritis in Han ChineseChanggui Li, Zhiqiang Li, Shiguo Liu, et al.
Vaccine|April 20, 2021
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trialJing Pu, Qin Yu, Zhifang Yin, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
International Journal of Rheumatic Diseases|August 25, 2025
2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common ComorbiditiesChanggui Li, Mingshu Sun, Zhen Liu, et al.
Annals of the Rheumatic Diseases|April 19, 2026
Musculoskeletal ultrasound findings in people with asymptomatic hyperuricemia: baseline analysis from the Transitions in Gout Research (TIGER) study using the OMERACT gout ultrasound semiquantitative scoring systemSarah Stewart, Gregory D Gamble, William J Taylor, et al.
Science (New York, N.Y.)|May 8, 2020
Development of an inactivated vaccine candidate for SARS-CoV-2Qiang Gao, Linlin Bao, Haiyan Mao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2024
Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout CohortAichang Ji, Yang Sui, Xiaomei Xue, et al.
Science Bulletin|May 31, 2022
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2Junyu Chen, Pui Wang, Lunzhi Yuan, et al.
Nature Genetics|October 10, 2017
Genome-wide association analysis identifies 30 new susceptibility loci for schizophreniaZhiqiang Li, Jianhua Chen, Hao Yu, et al.
The Lancet. Respiratory Medicine|November 18, 2023
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
Nature Communications|July 11, 2023
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamstersLiang Zhang, Yao Jiang, Jinhang He, et al.
Nature Communications|May 14, 2015
Genome-wide association analysis identifies three new risk loci for gout arthritis in Han ChineseChanggui Li, Zhiqiang Li, Shiguo Liu, et al.
Vaccine|April 20, 2021
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trialJing Pu, Qin Yu, Zhifang Yin, et al.
Pageof 26